IWP
NVO

Icon Wealth Partners’s Novo Nordisk NVO Stock Holding History

Icon Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.02M Buy
22,233
+9,189
+70% +$809K 0.23% 83
2023
Q2 		$1.06M Sell
13,044
-956
-7% -$78.1K 0.11% 129
2023
Q1 		$1.11M Buy
+14,000
New +$993K 0.12% 130
2022
Q2 		$830K Sell
14,896
-3,542
-19% -$197K 0.1% 153
2022
Q1 		$1.02M Sell
18,438
-40
-0.2% -$2.05K 0.1% 146
2021
Q4 		$1.03M Buy
18,478
+116
+0.6% +$6.28K 0.1% 149
2021
Q3 		$881K Buy
18,362
+1,268
+7% +$61.3K 0.09% 170
2021
Q2 		$716K Buy
17,094
+1,412
+9% +$54.7K 0.08% 190
2021
Q1 		$529K Buy
15,682
+1,256
+9% +$44.7K 0.07% 207
2020
Q4 		$504K Buy
14,426
+2,998
+26% +$104K 0.08% 173
2020
Q3 		$397K Buy
11,428
+2,656
+30% +$88.5K 0.08% 165
2020
Q2 		$287K Sell
8,772
-490
-5% -$15.6K 0.07% 190
2020
Q1 		$279K Sell
9,262
-762
-8% -$22.7K 0.11% 108
2019
Q4 		$290K Sell
10,024
-204
-2% -$5.65K 0.09% 125
2019
Q3 		$264K Sell
10,228
-28
-0.3% -$708 0.09% 124
2019
Q2 		$262K Sell
10,256
-160
-2% -$3.95K 0.09% 125
2019
Q1 		$272K Buy
10,416
+348
+3% +$8.55K 0.1% 124
2018
Q4 		$232K Sell
10,068
-4,854
-33% -$108K 0.11% 128
2018
Q3 		$352K Buy
14,922
+8,900
+148% +$217K 0.15% 113
2018
Q2 		$139K Sell
6,022
-984
-14% -$23.4K 0.06% 199
2018
Q1 		$175K Sell
7,006
-1,056
-13% -$27.7K 0.09% 177
2017
Q4 		$216K Buy
+8,062
New +$205K 0.11% 165

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Icon Wealth Partners's NVO Position: Q3 2023 in Review

Icon Wealth Partners increased its Novo Nordisk (NVO) stake by 70% in Q3 2023, buying an estimated $809K and bringing the position to 22,233 shares worth $2.02M. The position accounts for 0.23% of the portfolio, ranked #83.

Icon Wealth Partners first reported a position in NVO in Q4 2017 and has held it in 22 quarters since. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • Icon Wealth Partners held 22,233 shares of Novo Nordisk worth $2.02M as of Q3 2023.
  • Icon Wealth Partners bought 9,189 Novo Nordisk shares in Q3 2023, an estimated $809K.
  • Novo Nordisk made up 0.23% of Icon Wealth Partners's portfolio in Q3 2023, its #83 holding.
  • Icon Wealth Partners first reported a position in Novo Nordisk in Q4 2017 and has held it in 22 quarters since.
  • 1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.